Long-term treatment with pacritinib on a compassionate use basis in patients with advanced myelofibrosis

• Claire Harrison,
• Abdulraheem Yacoub,
• Bart Scott,
• Adam Mead,
• Aaron T. Gerds,
• Jean-Jacques Kiladjian,
• Ruben Mesa,
• Miklos Egyed,
• Christof Scheid,
• Valentin Garcia Gutierrez,
• Jennifer O’Sullivan,
• Sarah Buckley,
• Kris Kanellopoulos,
• John Mascarenhas

Affiliations

Claire Harrison

Guy's and St Thomas' NHS Foundation Trust, London

Abdulraheem Yacoub

The University of Kansas Cancer Center, Kansas City

Bart Scott

Fred Hutchinson Cancer Research Center, Seattle, WA

Adam Mead

University of Oxford, Oxford

Aaron T. Gerds

Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Jean-Jacques Kiladjian

Hôpital Saint-Louis, Université Paris Cité, Paris

Ruben Mesa

Mays Cancer Center at UT Health San Antonio, San Antonio

Miklos Egyed

Somogy County Mór Kaposi General Hospital, Kaposvár

Christof Scheid

Universitätsklinikum Köln (AöR), Cologne

Valentin Garcia Gutierrez

Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid

Jennifer O’Sullivan

University of Oxford, Oxford

Sarah Buckley

CTI Biopharma Inc, Seattle, WA

Kris Kanellopoulos

CTI Biopharma Inc, Seattle, WA

John Mascarenhas

Icahn School of Medicine at Mount Sinai, New York